Position in GUTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$91,600
-$348,400 QoQ
Shares Held
200,000
0.0% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GUTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PEAK6 LLC holds $24,388,144 across 19 Biotechnology names. GUTS ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
108,604 | $5,166,292 | |
| 2 | BNTX |
BioNTech SE
|
43,054 | $3,826,639 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,716 | $3,214,732 | |
| 4 | MRNA |
Moderna, Inc.
|
60,583 | $3,077,616 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
34,419 | $2,584,522 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,955 | $2,283,150 | |
| 7 | INSM |
INSMED Inc
|
7,926 | $1,296,059 | |
| 8 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
107,163 | $656,909 |
All Filings in GUTS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $91,600 | 200,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $440,000 | 200,000 | Shares | Defined | 2026-03-12 | |
| 2025-09-30 | $397,500 | 250,000 | Shares | Defined | 2026-03-31 | |
| No filing history on record for this holder in this stock. | ||||||